Are You Seeking Relief for Lower Back Pain?
You may qualify for a local clinical research study evaluating an investigational treatment.
We are looking for adults living with severe, chronic lower back pain to take part in a local clinical research study evaluating an investigational treatment. All study-related care is provided at no cost.
Participants will receive compensation for their time, including up to $350 per night for required clinic stays.
Is This Study Right for Me?
We are looking for participants who have exhausted standard options. You may qualify for this study if you:
- Are an adult living with stable, moderate to severe chronic lower back pain.
- Have tried at least 6 weeks of physical therapy and 3 or more types of pain medications without sufficient relief.
- Have previously had at least one back procedure, such as a spinal injection or surgery.
- Have been a non-smoker for at least 1 year.
- Are willing and able to complete a 2-3 day inpatient clinic stay for observation.
What is this Study Investigating?
This clinical research study is evaluating a treatment specifically for individuals who suffer from uncontrolled, chronic, moderate to severe lower back pain. It is aimed at patients whose pain has not been effectively managed by standard treatments, such as physical therapy, prescription medications, and previous back procedures.
The study is evaluating an investigational medication known as CNTX-3001. This medication is designed to activate specific receptors in the nervous system that have been shown to produce strong pain-relieving effects.
During the study, eligible participants will receive a single dose of the investigational medication (or a placebo) administered as an injection by one of our expert healthcare professionals. Because of how the injection is administered, participants will be carefully monitored by our medical staff during a required and paid 2-to-3-night inpatient observation stay immediately following the procedure.
See If you Qualify
Complete the secure form below or call us at 707-252-9606. Our team will contact you within 48 hours.
Study Participation and Your Safety
Participant safety is our number one priority during every stage of the study process. All research studies are carefully supervised, monitored, and documented. Every research study is reviewed and approved by a special group of people called an Institutional Review Board (IRB) or an Ethics Committee (EC), which is made up of scientists, nonscientist professionals, and members of the public. They make sure that participants’ rights are protected, and they seek to avoid exposure to unnecessary risks. IRBs and ECs will only approve studies that they think could help
answer important medical questions.
While the research study is ongoing, a team of study doctors and nurses at the study site will closely monitor your health. If you have questions or concerns at any point throughout the study, a study staff member is available.
Your participation is voluntary, and you are free to withdraw at any time for any reason. Although others can help make up your mind, the final decision is yours to make. Your privacy will be maintained throughout the study.
About Neurovations Research
Neurovations Research, founded in 2010, is at the forefront of innovation in the field of pain and neuromodulation. CEO and founder Dr. Eric Grigsby has led clinical trials with more than fifty companies, partnering with industry leaders and early-stage companies in medical device (Phase I-IV) and pharmaceutical trials (Phase II-IV), including first-in-man medical device trials, double-blinded and placebo-controlled trials.